For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...

DelveInsight's Interferons Market Insights report provides the current and forecast market analysis, individual leading ...

Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of ...

We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other undervalued stocks ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first ...

Dr Andrew Bomback reflects on how IgA nephropathy treatment has evolved from limited options like prednisone to a growing arsenal of targeted therapies.

TOKYO -- Swiss pharmaceutical company Novartis plans to start mass production of radiopharmaceuticals, a type of ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Liu Jiakun, Chinese architect and founder of Jiakun Architects since 1999, is the 54th winner of the Pritzker Architecture ...

Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple effect is already being felt across biopharma.

In this article, we will look at the 11 Best Undervalued Stocks to Invest in Now.